Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

EPA:ABLD - Euronext Paris - Matif - FR001400AHX6 - Common Stock - Currency: EUR

5.4  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ABLD. ABLD was compared to 16 industry peers in the Trading Companies & Distributors industry. While ABLD seems to be doing ok healthwise, there are quite some concerns on its profitability. ABLD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ABLD had positive earnings in the past year.
In the past year ABLD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ABLD reported negative net income in multiple years.
In the past 5 years ABLD reported 4 times negative operating cash flow.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M

1.2 Ratios

With a Return On Assets value of 1.36%, ABLD perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.70%, ABLD is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROIC N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

ABLD's Profit Margin of 3.13% is fine compared to the rest of the industry. ABLD outperforms 68.75% of its industry peers.
In the last couple of years the Profit Margin of ABLD has declined.
The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300 400

More info and screens

5

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ABLD has about the same amount of shares outstanding.
ABLD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABLD has a worse debt to assets ratio.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

ABLD has an Altman-Z score of 8.71. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.
ABLD has a better Altman-Z score (8.71) than 100.00% of its industry peers.
ABLD has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, ABLD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 8.71
ROIC/WACCN/A
WACC7.79%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

ABLD has a Current Ratio of 2.06. This indicates that ABLD is financially healthy and has no problem in meeting its short term obligations.
ABLD has a Current ratio of 2.06. This is in the better half of the industry: ABLD outperforms 62.50% of its industry peers.
A Quick Ratio of 1.92 indicates that ABLD should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.92, ABLD belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.92
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ABLD have decreased strongly by -70.74% in the last year.
Measured over the past years, ABLD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -66.52% on average per year.
ABLD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.26%.
The Revenue has been growing by 74.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%

3.2 Future

ABLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 162.07% yearly.
ABLD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.29% yearly.
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 540.00 indicates a quite expensive valuation of ABLD.
Based on the Price/Earnings ratio, ABLD is valued a bit more expensive than 62.50% of the companies in the same industry.
ABLD is valuated expensively when we compare the Price/Earnings ratio to 25.82, which is the current average of the S&P500 Index.
ABLD is valuated quite expensively with a Price/Forward Earnings ratio of 88.24.
ABLD's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ABLD to the average of the S&P500 Index (21.76), we can say ABLD is valued expensively.
Industry RankSector Rank
PE 540
Fwd PE 88.24
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

ABLD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABLD's earnings are expected to grow with 162.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y162.07%

More info and screens

1

5. Dividend

5.1 Amount

ABLD has a yearly dividend return of 0.92%, which is pretty low.
ABLD's Dividend Yield is slightly below the industry average, which is at 2.64.
With a Dividend Yield of 0.92, ABLD pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABLD.PA Yearly Dividends per shareABLD.PA Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04

5.3 Sustainability

DPN/A
EPS Next 2Y324.26%
EPS Next 3Y162.07%
ABLD.PA Yearly Income VS Free CF VS DividendABLD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M

More info and screens

ABL DIAGNOSTICS

EPA:ABLD (5/23/2025, 7:00:00 PM)

5.4

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.64%
Ins Owner ChangeN/A
Market Cap86.99M
Analysts85.71
Price Target6.28 (16.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 540
Fwd PE 88.24
P/S 14.74
P/FCF N/A
P/OCF 109.48
P/B 12.7
P/tB 20.71
EV/EBITDA N/A
EPS(TTM)0.01
EY0.19%
EPS(NY)0.06
Fwd EY1.13%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY0.91%
SpS0.37
BVpS0.43
TBVpS0.26
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.13%
GM N/A
FCFM N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 13.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.92
Altman-Z 8.71
F-Score4
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-76.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.32%
EBIT Next 3Y106.69%
EBIT Next 5YN/A
FCF growth 1Y89.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y541.44%
OCF growth 3YN/A
OCF growth 5Y62.76%